We take an active role in our portfolio companies, contributing expertise in drug discovery, development and operations.
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.
We aim to work with our portfolio companies to help them deliver maximum patient value by contributing both capital and expertise.
Selected Invested Funds
Arix Bioscience supports medical innovation at all stages of development and has access to breakthrough academic science.
Pappas is dedicated to furthering life science discoveries and delivering groundbreaking solutions to market.
Qiming drives innovation and growth of business enterprises and promotes overall industry advancement and social development.